VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Biokin's Bispecific ADC Files for Third Indication: A New Milestone in TNBC Treatment
Biokin's Bispecific ADC Files for Third Indication: A New Milestone in TNBC Treatment
Jun 11, 2026 12:26 CST Updated 13:01
Share:
Biokin
Pharmaceutical R&D Developer
